Incyte today announced complete safety and efficacy data from all patients (n=16) enrolled in the Phase 1/2 multidose study of VGA039 (latarcibart), a novel, Protein S-targeting, investigational ...
Total Metals Corp. is pleased to announce the results from the fifteen remaining unreleased drill-holes in its 8,408 metre, 25 hole winter drilling program at the Electrolode critical metals property, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results